Breakingviews – Breakdown: The scramble for a Covid-19 vaccine – Reuters

NEW YORK/LONDON (Reuters Breakingviews) – Pharmaceutical groups such as AstraZeneca and Pfizer may soon get regulators’ blessing for new coronavirus inoculations. A successful vaccine could ease a crisis that the Congressional Budget Office estimates will cost the United States alone some $8 trillion. Yet doubts over efficacy will linger, and manufacturing challenges mean poorer countries may have to wait. The reward for drugmakers is equally uncertain.
HOW DO THE POTENTIAL VACCINES WORK?
Th…

Click here to view the original article.